Skip to main content


Page 4 of 7

  1. Tumor-promoting factors (TPF) and metabolic reprogramming are hallmarks of cancer cell growth. This study is designed to combine the newly synthesized two nanocomposites DDM (HA-FA-2DG@DCA@MgO) and AF (HA-FA-A...

    Authors: Noura M. Thabet, Mohamed K. Abdel-Rafei, Gharieb S. El-Sayyad, Mohamed Abd Elkodous, Adel Shaaban, Yi-Chun Du, Laila Ahmed Rashed and Mostafa A. Askar
    Citation: Cancer Nanotechnology 2022 13:16
  2. Nanoparticles play a crucial role in nanodiagnostics, radiation therapy of cancer, and they are now widely used to effectively deliver drugs to specific sites, targeting whole organs and down to single cells, ...

    Authors: Dmitri V. Alexandrov, Nickolay Korabel, Frederick Currell and Sergei Fedotov
    Citation: Cancer Nanotechnology 2022 13:15
  3. Hepatocellular carcinoma (HCC) is one of the most dangerous cancers in all the world. This study focused on prevention and therapy of hepatocellular carcinoma (HCC) using Moringa oleifera extract combined with vi...

    Authors: Eman M. M. Ebrahem, Galal H. Sayed, Gehan N. A. Gad, Kurls E. Anwer and Adli A. Selim
    Citation: Cancer Nanotechnology 2022 13:14
  4. Helicobacter pylori (H. pylori) eradication plays a crucial role in gastric cancer prevention, but the antimicrobial resistance of H. pylori is obstructing this elimination process. In this study, we developed na...

    Authors: Fansen Meng, Hongjin Tao, Yan Mi, Tianyu Yang, Xuanping Wang, Yuyo Go, Yunjuan Lin and Gangshi Wang
    Citation: Cancer Nanotechnology 2022 13:13
  5. In the current study, folic acid-conjugated PEG-PCL-PEG triblock copolymer were synthesized and loaded with 5-fluorouracil and magnetite nanoparticles (5-FU-SPION-PEG-PCL-PEG-FA) for targeted delivery of drug ...

    Authors: Parvin Sadat Mirzaghavami, Samideh Khoei, Sepideh Khoee and Sakine Shirvalilou
    Citation: Cancer Nanotechnology 2022 13:12
  6. Inherent limitations of single cancer therapy are overcome by multi-therapy modality, which integrates characteristics of each therapeutic modality and material chemistry. The multi-modal method has the potent...

    Authors: Kanglin Liu, Shaoying Yan, Zhengshu Liu, Dan Wang, Qing Yang, Xinyun Jiang, Liuxian Chen and Hua Tang
    Citation: Cancer Nanotechnology 2022 13:11
  7. Immune checkpoint blockade (ICB)-based cancer immunotherapy presents promising efficacy in cancer treatment. However, only a small portion of patients show responsiveness to the treatment, which is partially c...

    Authors: Yuxia Ma, Yi Liu, Ying Zhi, Haibin Wang, Mei Yang, Jieting Niu, Li Zhao and Pengsheng Wang
    Citation: Cancer Nanotechnology 2022 13:10
  8. Recently, biosensors have become popular analytical tools for small analytes due to their high sensitivity and wide analytical range. In the present work, development of a novel biosensing method based on tung...

    Authors: Ramin Pourakbari, Mehdi Yousefi, Balal Khalilzadeh, Mahsa Haddad Irani-nezhad, Alireza Khataee, Leili Aghebati-Maleki, Alireza Soleimanian, Amin Kamrani, Forough Chakari-Khiavi, Rozita Abolhasan, Morteza Motallebnezhad, Farhad Jadidi-Niaragh, Bahman Yousefi, Hossein Samadi Kafil, Mohammad Hojjat-Farsangi and Mohammad-Reza Rashidi
    Citation: Cancer Nanotechnology 2022 13:7
  9. There is growing potential for nanocarrier-based drug delivery in cancer. However, an incomplete understanding of nano–bio interactions and the challenges regarding processing and fabrication in scale-up engin...

    Authors: Mujibur Khan, Md. Mahmudul Hasan, Anne Barnett, Raziye Piranlioglu, Mohammad Rashid, Ahmet Alptekin and Ali Arbab
    Citation: Cancer Nanotechnology 2022 13:6
  10. RNA interference holds tremendous potential in the treatment of malignant tumors. However, efficient and biocompatible delivery methods are needed for systemic delivery of small interfering RNA (siRNA). In thi...

    Authors: Shanrong Shu, Xiaoping Liu, Ming Xu, Yaduan Lin and Ruiman Li
    Citation: Cancer Nanotechnology 2022 13:5
  11. Chemotherapy is widely used to treat hepatocellular carcinoma (HCC). Although sorafenib (SO) is the only chemotherapy drug approved by FDA for treatment of HCC, it is associated with several disadvantages incl...

    Authors: Huan Yue, Luxia Gou, Zhenrong Tang, Yuyang Liu, Shengchun Liu and Hua Tang
    Citation: Cancer Nanotechnology 2022 13:4
  12. Zinc oxide nanoparticles (ZONs) are a type of nanomaterial that has presented anti-cancer properties in breast cancer (BC). However, the function of ABCC9 in BC and its correlation with ZONs are still elusive.

    Authors: Yang Li, Cui Jiang, Xiaoxue Zhang, Zhixuan Liao, Long Chen, Shuang Li, Shunxiong Tang, Zhe Fan and Qiang Zhang
    Citation: Cancer Nanotechnology 2022 13:3
  13. Breast cancer is the most frequently occurring cancer among women. Baicalin has been shown to inhibit breast cancer proliferation, but poor aqueous solubility and unknown mechanism of action limit its applicat...

    Authors: Fengjie Liu, Meng Lan, Baoqi Ren, Lihong Li, Tengteng Zou, Zhaodi Kong, Dongmei Fan, Tiange Cai and Yu Cai
    Citation: Cancer Nanotechnology 2022 13:2
  14. Recent advances from studies of graphene and graphene-based derivatives have highlighted the great potential of these nanomaterials as migrastatic agents with the ability to modulate tumor microenvironments. N...

    Authors: Nazely Diban, Marián Mantecón-Oria, María T. Berciano, Alba Puente-Bedia, María J. Rivero, Ane Urtiaga, Miguel Lafarga and Olga Tapia
    Citation: Cancer Nanotechnology 2022 13:1
  15. The purpose of the present study was to evaluate the efficacy of chemo-magnetic hyperthermia (MH), a combination of alternating magnetic field (AMF) and superparamagnetic nanoparticles (SPIONs) coated with Pol...

    Authors: Saba Jahangiri, Samideh Khoei, Sepideh Khoee, Majid Safa, Sakine Shirvalilou and Vahid Pirhajati Mahabadi
    Citation: Cancer Nanotechnology 2021 12:34
  16. Platinum-based drugs are widely used in cancer therapy, but are known for toxic side effects and resistance. Combinational drug delivery represents an effective chemotherapeutic strategy, but often leads to an...

    Authors: B. Rabindran Jermy, D. Almohazey, W. A. Alamoudi, R. M. Palanivel, Nora AlSudairi, H. Dafalla, A. A. Almofleh, T. M. Alfareed and Vijaya Ravinayagam
    Citation: Cancer Nanotechnology 2021 12:33
  17. Microwave ablation (MWA) has become an alternative treatment for unresectable hepatocellular carcinoma (HCC), but it does not eliminate the risk of recurrence and metastasis after treatment. Recent studies hav...

    Authors: Jian Hu, Wenceng Pei, Zhenyou Jiang and Zihuang Li
    Citation: Cancer Nanotechnology 2021 12:32
  18. In recent years, targeted drug delivery strategies have received special attention from the scientific world due to advantages such as more effective therapy and reduction of side effects. The principle of ope...

    Authors: Gabriela Siemiaszko, Katarzyna Niemirowicz-Laskowska, Karolina H. Markiewicz, Iwona Misztalewska-Turkowicz, Ewelina Dudź, Sylwia Milewska, Paweł Misiak, Izabela Kurowska, Anna Sadowska, Halina Car and Agnieszka Z. Wilczewska
    Citation: Cancer Nanotechnology 2021 12:31
  19. Self-emulsifying drug delivery systems (SEDDSs) have attracted attention because of their effects on solubility and bioavailability of lipophilic compounds. Herein, a SEDDS loaded with lycopene purified from r...

    Authors: Andreanne G. Vasconcelos, Ana Luisa A. N. Barros, Wanessa F. Cabral, Daniel C. Moreira, Ingrid Gracielle M. da Silva, Amandda É. Silva-Carvalho, Miguel P. de Almeida, Lucas F. F. Albuquerque, Raimunda C. dos Santos, Ana Karolinne S. Brito, Felipe Saldanha-Araújo, Daniel D. R. Arcanjo, Maria do Carmo C. Martins, Tatiana K. dos S. Borges, Sônia N. Báo, Alexandra Plácido…
    Citation: Cancer Nanotechnology 2021 12:30
  20. The problems associated with the poor water solubility of anticancer drugs are one of the most important challenges in achieving effective cancer therapy. The present study was designed to evaluate the effect ...

    Authors: Jundong Wang, Tianhao Li, Chaochi Yue, Sen Zhong, Xiangdong Yang, Jun Li and Yuanzhi Li
    Citation: Cancer Nanotechnology 2021 12:29
  21. Phytochemicals and plant extracts are showing promising anticancer potentials. In the current study, the volatile faction (essential oil) of Nigella sativa seeds was evaluated against some hepatocellular carcinom...

    Authors: Ahmed A. Abd-Rabou and Amr E. Edris
    Citation: Cancer Nanotechnology 2021 12:28
  22. Gold nanoparticles (AuNPs) are considered as promising agents to increase the radiosensitivity of tumor cells. However, the biological mechanisms of radiation enhancement effects of AuNPs are still not well un...

    Authors: Alexander P. Klapproth, Jan Schuemann, Stefan Stangl, Tianwu Xie, Wei Bo Li and Gabriele Multhoff
    Citation: Cancer Nanotechnology 2021 12:27
  23. Theranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in r...

    Authors: Madeeha Shahzad Lodhi, Muhammad Tahir Khan, Saira Aftab, Zahoor Qadir Samra, Heng Wang and Dong Qing Wei
    Citation: Cancer Nanotechnology 2021 12:26
  24. Disulfiram (DS), in the presence of copper (Cu), exhibited potent broad anticancer activity. However, its clinical application is limited due to the poor solubility and stability. Hence, a novel nanocombinatio...

    Authors: Marwa M. Abu‑Serie and Marwa Eltarahony
    Citation: Cancer Nanotechnology 2021 12:25
  25. Berberine (Ber) is a herbal alkaloid with pharmacological activity in general and a high anticancer potency in particular. However, due to its low bioavailability, the difficulty in reaching a target and choos...

    Authors: Anna Grebinyk, Svitlana Prylutska, Sergii Grebinyk, Maxim Evstigneev, Iryna Krysiuk, Tetiana Skaterna, Iryna Horak, Yanfang Sun, Liudmyla Drobot, Olga Matyshevska, Yuriy Prylutskyy, Uwe Ritter and Marcus Frohme
    Citation: Cancer Nanotechnology 2021 12:24
  26. The apoptosis (a cascade of biochemical reactions leading to suicide of damaged biological cells) is blocked in the cancer cells because of impossibility of cytochrome c (cytC) go out from the mitochondria. Howev...

    Authors: Svetlana H. Hristova and Alexandar M. Zhivkov
    Citation: Cancer Nanotechnology 2021 12:23
  27. The role of epithelial–mesenchymal transition (EMT) involved in breast cancer metastasis and chemoresistance has been increasingly recognized. However, it is necessary to search for more effective strategies t...

    Authors: Tengteng Zou, Meng Lan, Fengjie Liu, Lihong Li, Tiange Cai, Huaqin Tian and Yu Cai
    Citation: Cancer Nanotechnology 2021 12:22
  28. Immune evasion is an important hallmark of cancer progression and tumourigenesis. Among the cancer types, cervical cancer has very high global prevalence, severely affecting female reproductive health. Its pre...

    Authors: Rituparna Chakraborty, Ujjal Bose, Goutam Pawaskar, Satish Rao Bola Sadashiva and Ritu Raval
    Citation: Cancer Nanotechnology 2021 12:21
  29. Cancer is one of the most common incident in the world, with malignant tumors having a death rate of up to 19%. A new method of treating cancer cells effectively with minimal cytotoxicity is needed. In the fie...

    Authors: Naseer Ullah Khan, Jing Lin, Muhammad Rizwan Younas, Xukun Liu and Liming Shen
    Citation: Cancer Nanotechnology 2021 12:20
  30. Combination chemo-photothermal therapy appears to be one of the next generations of cancer treatment. In this study hollow gold nanostars (HGNSs) and gold nanocages (GNCs) were synthesized and stabilized with ...

    Authors: Asrin Pakravan, Mehdi Azizi, Fariborz Rahimi, Farhad Bani, Farideh Mahmoudzadeh, Roya Salehi and Mehrdad Mahkam
    Citation: Cancer Nanotechnology 2021 12:19
  31. In the last decade, graphene oxide-based nanomaterials, such as graphene oxide (GO) and reduced graphene oxide (rGO), have attracted more and more attention in the field of biomedicine. Due to the versatile su...

    Authors: Lijun Liu, Qingming Ma, Jie Cao, Yang Gao, Shangcong Han, Yan Liang, Tingting Zhang, Yang Song and Yong Sun
    Citation: Cancer Nanotechnology 2021 12:18
  32. Glioblastoma multiforme (GBM) is one of the most daunting issues to modern therapeutics, with a higher mortality rate post-diagnosis. Temozolomide (TMZ) is the only available treatment; however, the frequent r...

    Authors: Fawad Ur Rehman, Mohd Ahmar Rauf, Sajjad Ullah, Sana Shaikh, Aqsa Qambrani, Pir Muhammad and Sumaira Hanif
    Citation: Cancer Nanotechnology 2021 12:17
  33. In our earlier work, we identified microRNA-10b (miR10b) as a master regulator of the viability of metastatic tumor cells. This knowledge allowed us to design a miR10b-targeted therapeutic consisting of an ant...

    Authors: Mariane Le Fur, Alana Ross, Pamela Pantazopoulos, Nicholas Rotile, Iris Zhou, Peter Caravan, Zdravka Medarova and Byunghee Yoo
    Citation: Cancer Nanotechnology 2021 12:16
  34. Melittin, a peptide component of honey bee venom, is an appealing candidate for cancer therapy. In the current study, melittin, melittin-loaded niosome, and empty niosome had been optimized and the anticancer ...

    Authors: Farnaz Dabbagh Moghaddam, Iman Akbarzadeh, Ehsan Marzbankia, Mahsa Farid, Leila khaledi, Amir Hossein Reihani, Mehrnoosh Javidfar and Pejman Mortazavi
    Citation: Cancer Nanotechnology 2021 12:14
  35. Brain metastases from non-small cell lung cancer (NSCLC) remain one of the most challenging malignancies. Afatinib (Afa) is an orally administered irreversible ErbB family blocker approved for epidermal growth...

    Authors: Yu-Li Lo, Hua-Ching Lin, Shu-Ting Hong, Chih-Hsien Chang, Chen-Shen Wang and Anya Maan-Yuh Lin
    Citation: Cancer Nanotechnology 2021 12:13
  36. Neuroblastoma is the most common extracranial solid malignancy in childhood which, despite the current progress in radiotherapy and chemotherapy protocols, still has a high mortality rate in high risk tumors. ...

    Authors: William Liu, Salida Mirzoeva, Ye Yuan, Junjing Deng, Si Chen, Barry Lai, Stefan Vogt, Karna Shah, Rahul Shroff, Reiner Bleher, Qiaoling Jin, Nghia Vo, Remon Bazak, Carissa Ritner, Stanley Gutionov, Sumita Raha…
    Citation: Cancer Nanotechnology 2021 12:12
  37. Cancer constitutes group of diseases responsible for the second largest cause of global death, and it is currently considered one of the main public health concerns nowadays. Early diagnosis associated with th...

    Authors: Ana Luísa G. Silva, Natália V. Carvalho, Leonardo G. Paterno, Ludmilla D. Moura, Cleber L. Filomeno, Eneida de Paula and Sônia N. Báo
    Citation: Cancer Nanotechnology 2021 12:11
  38. In this label-free bioassay, an electrochemiluminescence (ECL) immunosensor was developed for the quantification of breast cancer using HER-2 protein as a metastatic biomarker.

    Authors: Hassan Nasrollahpour, Ibrahim Isildak, Mohammad-Reza Rashidi, Esmat Alsadat Hashemi, Abdolhosein Naseri and Balal Khalilzadeh
    Citation: Cancer Nanotechnology 2021 12:10
  39. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Monika Ruzycka-Ayoush, Patrycja Kowalik, Agata Kowalczyk, Piotr Bujak, Anna M. Nowicka, Maria Wojewodzka, Marcin Kruszewski and Ireneusz P. Grudzinski
    Citation: Cancer Nanotechnology 2021 12:9

    The original article was published in Cancer Nanotechnology 2021 12:8

  40. Lung cancer is one of the most frequently diagnosed cancers all over the world and is also one of the leading causes of cancer-related mortality. The main treatment option for small cell lung cancer, conventio...

    Authors: Monika Ruzycka-Ayoush, Patrycja Kowalik, Agata Kowalczyk, Piotr Bujak, Anna M. Nowicka, Maria Wojewodzka, Marcin Kruszewski and Ireneusz P. Grudzinski
    Citation: Cancer Nanotechnology 2021 12:8

    The Correction to this article has been published in Cancer Nanotechnology 2021 12:9

  41. Magnetic fluid hyperthermia (MFH) is a successful nanotechnology application in recent decade where a biocompatible magnetic fluid is used to kill cancer cells in a controlled heating using AC magnetic field. ...

    Authors: Anand Bhardwaj, Neeraj Jain and Kinnari Parekh
    Citation: Cancer Nanotechnology 2021 12:7
  42. The skin is both a target and a potential conduit for the delivery of drugs, but its cornified cell layer resists penetration by most molecules. This study investigated the potential of superparamagnetic iron ...

    Authors: Vanisri Raviraj, Binh T. T. Pham, Byung J. Kim, Nguyen T. H. Pham, Lai F. Kok, Nicole Painter, Naomi C. Delic, Stephen K. Jones, Brian S. Hawkett and J. Guy Lyons
    Citation: Cancer Nanotechnology 2021 12:6
  43. Despite advances in glioblastoma (GBM) treatments, current approaches have failed to improve the overall survival of patients. The oncogene BMI-1, a core member of the polycomb group proteins, is a potential n...

    Authors: Elham Poonaki, Fatemeh Ariakia, Mohammad Jalili-Nik, Mehdi Shafiee Ardestani, Gholamhossein Tondro, Fariborz Samini, Sepideh Ghasemi, Sajad Sahab-Negah and Ali Gorji
    Citation: Cancer Nanotechnology 2021 12:5
  44. In this study, we report on the synthesis, imaging, and radiosensitizing properties of ultrasmall β-NaGdF4:Yb50% nanoparticles as a multifunctional theranostic platform. The synthesized nanoparticles act as poten...

    Authors: Jossana A. Damasco, Tymish Y. Ohulchanskyy, Supriya Mahajan, Guanying Chen, Ajay Singh, Hilliard L. Kutscher, Haoyuan Huang, Steven G. Turowski, Joseph A. Spernyak, Anurag K. Singh, Jonathan F. Lovell, Mukund Seshadri and Paras N. Prasad
    Citation: Cancer Nanotechnology 2021 12:4
  45. Here, we examined the tumoricidal effect of Gemini surfactant nanoparticles enriched with curcumin on 3D spheroid HT-29 cells. The delivery of curcumin and other phytocompounds to the tumor niche is an importa...

    Authors: Zohre Zibaei, Esmaeil Babaei, Arezoo Rezaie Nezhad Zamani, Reza Rahbarghazi and Hewa Jalal Azeez
    Citation: Cancer Nanotechnology 2021 12:3
  46. The extracellular matrix (ECM) is a mosaic of various structural and functional proteins that cooperate with the cell, regulate adhesion, and consequently manage its further fate. Liver destruction is accompan...

    Authors: Malwina Sosnowska, Marta Kutwin, Barbara Strojny, Piotr Koczoń, Jarosław Szczepaniak, Jaśmina Bałaban, Karolina Daniluk, Sławomir Jaworski, André Chwalibog, Wiesław Bielawski and Ewa Sawosz
    Citation: Cancer Nanotechnology 2021 12:2
  47. Ovarian cancer is one of the deadliest gynecological malignancies. While the overall survival of ovarian cancer patients has slightly improved in recent years in the developed world, it remains clinically chal...

    Authors: Md. Nazir Hossen, Chandra Kumar Elechalawar, Virginie Sjoelund, Kathleen Moore, Robert Mannel, Resham Bhattacharya and Priyabrata Mukherjee
    Citation: Cancer Nanotechnology 2021 12:1

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.5
    5-year Journal Impact Factor: 5.1
    Source Normalized Impact per Paper (SNIP): 0.723
    SCImago Journal Rank (SJR): 0.671

    Speed 2023
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 93

    Usage 2023
    Downloads: 328,851
    Altmetric mentions: 109